The expansion is a good signal for an industry that slowed down, both in Chicago and nationwide, as interest rates rose and ...

Biotech was starting to show signs of recovery after years of investor pullback—until new tariffs and economic uncertainty ...

The global marketplace is here to stay. But global competition must take place on fair, transparent and enforceable terms, ...

The deal values the Swedish company at $1.2 billion, and the Biotage board recommended that shareholders accept the offer.

In an interview over the weekend, FDA Commissioner Dr. Marty Makary came across as “scientifically-grounded level-headed with regards to ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Alis Biosciences says its goal is to return to investors billions of dollars stuck on the balance sheets of “moribund” ...

As with pharmaceutical and healthcare companies, investing in American biotech stocks comes with the same degree of regulatory risk. All treatments need to approval from the Food & Drugs ...

America must invest at least $15 billion over the next five years to support its domestic biotechnology sector ... biopharmaceutical firms and investment companies to fund and collaborate on ...

Tom Brady reacts with pride — and a bit of humor Brady, a minority owner of the Las Vegas Raiders and now an emerging force in the biotech investment space, couldn’t hold back his excitement.

New figures have confirmed that the UK’s biotech sector received a massive boost from the COVID-19 pandemic last year, with investment levels soaring to £2.8 billion ($3.8 billion) from a level ...

The U.S.-based biotechnology company is also known for its ambitious goal of bringing back the extinct woolly mammoth by 2028. This dire wolf pup is among the first of its species born in around ...